A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial

Conclusions: Enarodustat corrects and maintains Hb levels in anemic patients with CKD not on dialysis.Am J Nephrol 2019;49:165 –174
Source: American Journal of Nephrology - Category: Neurology Source Type: research